Cost Analysis of Intravitreal Aflibercept vs Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy

This economic evaluation study compares the costs of intravitreal injections of aflibercept, 2 mg, vs pars plana vitrectomy plus panretinal photocoagulation for nonclearing vitreous hemorrhage secondary to proliferative diabetic retinopathy.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of ophthalmology (1960) 2021-07, Vol.139 (7), p.804-805
Hauptverfasser:	Young, Benjamin K, Johnson, Mark W, Wubben, Thomas J
Format:	Artikel
Sprache:	eng
Schlagworte:	Comments Costs and Cost Analysis Diabetes Diabetes Mellitus Diabetic retinopathy Diabetic Retinopathy - complications Diabetic Retinopathy - diagnosis Diabetic Retinopathy - drug therapy Hemorrhage Humans Laser Coagulation Letters Online First Receptors, Vascular Endothelial Growth Factor Recombinant Fusion Proteins Research Letter Retinopathy Vitrectomy Vitreous Hemorrhage - diagnosis Vitreous Hemorrhage - etiology Vitreous Hemorrhage - surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This economic evaluation study compares the costs of intravitreal injections of aflibercept, 2 mg, vs pars plana vitrectomy plus panretinal photocoagulation for nonclearing vitreous hemorrhage secondary to proliferative diabetic retinopathy.
ISSN:	2168-6165 2168-6173
DOI:	10.1001/jamaophthalmol.2021.1565